ACTRN12611000065998进行中（未招募）4 期
The effect of zolendronic acid on the clinical resolution of acute midfoot Charcot foot
Pirkanmaa Hospital District0 个研究点目标入组 40 人开始时间: 2011年1月19日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 18 Years 至 o limit（—）
- 性别
- All
入选标准
- •Patients with acute unilateral Charcot foot and type I or type II diabetes mellitus
排除标准
- •Serum creatine >400 umol/l
研究者
相似试验
已完成
Unknown
A new study to minimise the side effects of rapid maxillary expansioSide effects of rapid maxillary expansion (RME) on dental and buccal alveolar bone changesOral HealthISRCTN16744226Damascus University32
已完成
2 期
Evaluation of Zolendronic acid in the management of high grade osteosarcomaCTRI/2011/091/000189Tata Memorial Hospital60
已完成
不适用
Zoledronic acid injection prevents bone loss in spinal cord injury patientsCTRI/2018/03/012408Dr Satyaranjan Sethi60
进行中（未招募）
1 期
Zoledronic acid in patients with metastatic prostate cancer treated with abiraterone acetate: impact on bone mineral densityMetastatic castration-resistant prostate cancerMedDRA version: 18.0Level: PTClassification code 10036909Term: Prostate cancer metastaticSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2013-001146-34-FRCentre Oscar Lambret
已完成
不适用
To find out effect of Injection Zoledronic acid for treatment of bone weakening condition in patients having long term liver problems/damage.CTRI/2020/03/024247Pt BD Sharma PGIMS Rohtak49